Press coverage about Aemetis (NASDAQ:AMTX) has trended somewhat positive on Wednesday, according to Accern Sentiment Analysis. Accern ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Aemetis earned a daily sentiment score of 0.07 on Accern’s scale. Accern also gave media coverage about the specialty chemicals company an impact score of 46.0762020921792 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Shares of Aemetis (NASDAQ AMTX) opened at $0.72 on Wednesday. The company has a debt-to-equity ratio of -1.87, a current ratio of 0.37 and a quick ratio of 0.20. Aemetis has a 12-month low of $0.53 and a 12-month high of $2.50.

A number of research analysts have weighed in on AMTX shares. FBR & Co reaffirmed a “neutral” rating and issued a $2.00 price objective on shares of Aemetis in a research note on Saturday, August 19th. Zacks Investment Research raised shares of Aemetis from a “sell” rating to a “hold” rating in a research report on Tuesday, October 17th. Finally, B. Riley reissued a “neutral” rating on shares of Aemetis in a research report on Wednesday, November 1st.

TRADEMARK VIOLATION WARNING: This report was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The correct version of this report can be viewed at

About Aemetis

Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.

Insider Buying and Selling by Quarter for Aemetis (NASDAQ:AMTX)

Receive News & Stock Ratings for Aemetis Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis Inc and related stocks with our FREE daily email newsletter.